Olivia G. Thomas

Stockholm, AB 17177, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Treatment of multiple sclerosis with peptide-coupled red blood cells induces antigen-specific T regulatory cells.

Treatment of multiple sclerosis with peptide-coupled red blood cells induces antigen-specific T regulatory cells.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: August 31, 2026

HLA-dependent association between EBNA1 antibody levels and disability progression in multiple sclerosis.

HLA-dependent association between EBNA1 antibody levels and disability progression in multiple sclerosis.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: April 06, 2026

Lytic Epstein-Barr virus infection and emerging autoantibodies precede multiple sclerosis prodrome.

Lytic Epstein-Barr virus infection and emerging autoantibodies precede multiple sclerosis prodrome.

Journal: Brain : a journal of neurology

Published: February 12, 2026

Antibody reactivity against EBNA1 and GlialCAM differentiates multiple sclerosis patients from healthy controls.

Antibody reactivity against EBNA1 and GlialCAM differentiates multiple sclerosis patients from healthy controls.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: March 10, 2025

Anoctamin-2-specific T cells link Epstein-Barr virus to multiple sclerosis.

Anoctamin-2-specific T cells link Epstein-Barr virus to multiple sclerosis.

Journal: Cell

Published: January 29, 2025

Heightened Epstein-Barr virus immunity and potential cross-reactivities in multiple sclerosis.

Heightened Epstein-Barr virus immunity and potential cross-reactivities in multiple sclerosis.

Journal: PLoS pathogens

Published: November 22, 2023

Enhanced and cross-reactive in vitro memory B cell response against Epstein-Barr virus nuclear antigen 1 in multiple sclerosis.

Enhanced and cross-reactive in vitro memory B cell response against Epstein-Barr virus nuclear antigen 1 in multiple sclerosis.

Journal: Frontiers in immunology

Published: November 07, 2023

Mimicking the brain: Epstein-Barr virus and foreign agents as drivers of neuroimmune attack in multiple sclerosis.

Mimicking the brain: Epstein-Barr virus and foreign agents as drivers of neuroimmune attack in multiple sclerosis.

Journal: Frontiers in immunology

Published: September 29, 2023

Cross-reactive EBNA1 immunity targets alpha-crystallin B and is associated with multiple sclerosis.

Cross-reactive EBNA1 immunity targets alpha-crystallin B and is associated with multiple sclerosis.

Journal: Science advances

Published: May 17, 2023

Epstein-Barr virus and multiple sclerosis: moving from questions of association to questions of mechanism.

Epstein-Barr virus and multiple sclerosis: moving from questions of association to questions of mechanism.

Journal: Clinical & translational immunology

Published: March 10, 2023

The impact of hybrid immunity on immune responses after SARS-CoV-2 vaccination in persons with multiple sclerosis treated with disease-modifying therapies.

The impact of hybrid immunity on immune responses after SARS-CoV-2 vaccination in persons with multiple sclerosis treated with disease-modifying therapies.

Journal: European journal of neurology

Published: November 09, 2022

Identification of four novel T cell autoantigens and personal autoreactive profiles in multiple sclerosis.

Identification of four novel T cell autoantigens and personal autoreactive profiles in multiple sclerosis.

Journal: Science advances

Published: April 27, 2022

Showing 1-12 of 16

Last Updated: 09/26/2026